ANNE JABLONSKI: Open Payments
NPI 1669134821 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,537 in 16 payments from 10 companies in 2025. Trend: 2023 $1,967 · 2024 $2,502 · 2025 $1,537
Food & beverage: $1,537
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $511 |
| Insulet Corporation | 1 | $175 |
| CeQur Corporation | 1 | $163 |
| Amgen Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| SANOFI-AVENTIS U.S. LLC | 1 | $124 |
| Medtronic, Inc. | 2 | $101 |
| Alkermes, Inc. | 1 | $99 |
| Sequel Med Tech, LLC | 1 | $78 |
| Ascensia Diabetes Care Us Inc. | 1 | $36 |
Products named: Wegovy, Omnipod, CeQur Simplicity, EVENITY, JARDIANCE, TZIELD, MYCARELINK, ARISTADA.
Industry payments across NY — which companies pay providers there.
